Verastem (VSTM) Current Deferred Revenue (2011 - 2023)
Verastem's quarterly Current Deferred Revenue came in at $327000.0 in Q4 2023, up 68.56% quarter-over-quarter from $194000.0 in Q1 2018.
Verastem has reported Current Deferred Revenue for 9 years, with the latest figure at $327000.0 in Q4 2023.
- For the quarter ending Q4 2023, Current Deferred Revenue changed N/A year-over-year to $327000.0; the trailing twelve-month figure through Dec 2023 stood at $327000.0 (changed N/A YoY), and the FY2023 full-year result was $327000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2023 stood at $327000.0, up from $194000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $327000.0 in Q4 2023, with the low at $327000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 327,000.00 |
| Mar 31, 2018 | 194,000.00 |
| Dec 31, 2017 | 190,000.00 |
| Sep 30, 2017 | 186,000.00 |
| Jun 30, 2017 | 81,000.00 |
| Mar 31, 2017 | 179,000.00 |
| Dec 31, 2016 | 527,000.00 |
| Sep 30, 2016 | 171,000.00 |
| Jun 30, 2016 | 167,000.00 |
| Mar 31, 2016 | 164,000.00 |
| Dec 31, 2015 | 160,000.00 |
| Sep 30, 2015 | 156,000.00 |
| Jun 30, 2015 | 152,000.00 |
| Mar 31, 2015 | 148,000.00 |
| Dec 31, 2014 | 144,000.00 |
| Sep 30, 2014 | 137,000.00 |
| Jun 30, 2014 | 72,000.00 |
| Mar 31, 2014 | 28,000.00 |
| Dec 31, 2013 | 38,000.00 |
| Sep 30, 2013 | 43,000.00 |
| Jun 30, 2013 | 41,000.00 |
| Mar 31, 2013 | 39,000.00 |
| Dec 31, 2012 | 36,000.00 |
| Sep 30, 2012 | 34,000.00 |
| Jun 30, 2012 | 32,000.00 |
| Dec 31, 2011 | 27,000.00 |